Here is a look at the Top 10 pieces of content viewers were reading during the month of May. 1. American College of ...
June 4, 2024 — Caristo Diagnostics Limited, a global provider of cardiovascular disease diagnostics and risk prediction ...
June 3, 2024 — Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 3, 2024 — Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea ...
June 3, 2024 — Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease ...
June 3, 2024 — HighLife SAS, a medtech company focused on the development of a novel Trans-Septal Mitral Valve ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 31, 2024 — Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part ...
May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...
May 31, 2024 — CareDx, a leading precision medicine company focused on the discovery, development, and commercialization ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 31, 2024 — InfoBionic.ai and HBox.ai announced a groundbreaking partnership that brings together the leading AI ...
May 30, 2024 — Elixir Medical, a developer of technologies to treat cardiovascular and peripheral disease, announced ...
May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the ...
May 30, 2024 — Biotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC ...
May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...